中文名稱  粘液樣脂肪蛋白FUS1抗體品牌 

英文名稱  Anti-TLS/FUS

別    名 75 kDa DNA pairing protein; 75 kDa DNA-pairing protein; ALS6; Amyotrophic lateral sclerosis 6; FUS; FUS CHOP; Fus like protein; FUS-CHOP; FUS_HUMAN; FUS1; Fused in sarcoma; Fusion (involved in t(12;16) in malignant liposarcoma); Fusion derived from t(12;16) malignant liposarcoma; Fusion gene in myxoid liposarcoma; Heterogeneous nuclear ribonucleoprotein P2; hnRNP P2; hnRNPP2; Oncogene FUS; Oncogene TLS; POMp75; RNA binding protein FUS; RNA-binding protein FUS; TLS; TLS CHOP; TLS-CHOP; Translocated in liposarcoma; Translocated in liposarcoma protein.

產(chǎn)品屬性：

粘液樣脂肪蛋白FUS1抗體品牌 濃    度  1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit

產(chǎn)品類型   一抗  

研究領(lǐng)域     免疫學(xué) 染色質(zhì)和核信號 信號轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 表觀遺傳學(xué)

蛋白分子量  predicted molecular weight: 53kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human TLS

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

粘液樣脂肪蛋白FUS1抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 This gene encodes a multifunctional protein component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex. The hnRNP complex is involved in pre-mRNA splicing and the export of fully processed mRNA to the cytoplasm. This protein belongs to the FET family of RNA-binding proteins which have been implicated in cellular processes that include regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. Alternative splicing results in multiple transcript variants. Defects in this gene result in amyotrophic lateral sclerosis type 6. [provided by RefSeq].

Function : Binds both single-stranded and double-stranded DNA and promotes ATP-independent annealing of complementary single-stranded DNAs and D-loop formation in superhelical double-stranded DNA. May play a role in maintenance of genomic integrity.

Subunit : Component of nuclear riboprotein complexes. Interacts with ILF3, TDRD3 and SF1. Interacts through its C-terminus with SFRS13A. Interacts with OTUB1 and SARNP.

Subcellular Location : Nucleus.

Tissue Specificity : Ubiquitous.

Post-translational modifications : Arg-216 and Arg-218 are dimethylated, probably to asymmetric dimethylarginine.

DISEASE : Note=A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3.

Note=A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG.

Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. Note=The disease may be caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving FUS is found in a patient with angiomatoid fibrous histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1 protein.

Amyotrophic lateral sclerosis 6 (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Note=The disease is caused by mutations affecting the gene represented in this entry.

Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. Note=The disease is caused by mutations affecting the gene represented in this entry.

Similarity : Belongs to the RRM TET family.

Contains 1 RanBP2-type zinc finger.

Contains 1 RRM (RNA recognition motif) domain.

Database links : UniProtKB/Swiss-Prot: P35637.1

實驗流程：

全、新、優(yōu)、品、好四大特點：

粘液樣脂肪蛋白FUS1抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

技術(shù)外包服務(wù):

★粘液樣脂肪蛋白FUS1抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。

正在熱銷的相關(guān)產(chǎn)品：

Anti-AGEs/FITC 熒光素標記晚期糖基化終末產(chǎn)物抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-ER- Beta/FITC 熒光素標記雌激素受體β 抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh CPXCR1 /抗原77抗體 規(guī)格 0.2ml

CD68 CD68(多肽抗原) 0.5mg

ERG/KCNH2 英文名稱： 特異性離子通道蛋白抗體 0.1ml

Rhesus antibody Rh UCHL5IP 泛素羧基末端水解酶5互相作用蛋白1抗體 規(guī)格 0.2ml

Anti-ER- Beta/FITC 熒光素標記雌激素受體β 抗體IgGMulti-class antibodies規(guī)格： 0.2ml

GLP-1R peptide 胰素樣肽-1受體多肽Multi-class antibodies規(guī)格： 0.5mg

KLK3 KLK3 / Kallikrein 3 兔單抗 (FITC) Human

Rhesus antibody Rh Phospho-Cyclin B1(Ser147) 磷酸化周期素B1抗體 規(guī)格 0.1ml

顯影定影試劑A、B 各500ml 自產(chǎn)

ZDHHC-18 英文名稱： 鋅指蛋白Zdhhc18抗體 0.2ml

Phospho-CHK2 (ser516) 英文名稱： 磷酸化細胞周期檢測點激酶2抗體 0.1ml

KLK3 KLK3 / Kallikrein 3 兔單抗 (FITC) Human

TCF7L2(transcription factor 7-like 2) 轉(zhuǎn)錄因子7類似物2抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-Brucella 布魯氏菌抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh PDZK4 PDZ結(jié)構(gòu)域PDZK4蛋白抗體 規(guī)格 0.2ml

CD30 濃縮液 0.1ml 進口分裝

TSARG6 英文名稱： 生精細胞凋亡相關(guān)基因6抗體 0.1ml

CXCR2 英文名稱： 細胞表面趨化因子受體2抗體 0.1ml

Anti-Brucella 布魯氏菌抗體Multi-class antibodies規(guī)格： 0.2ml

VEGFA Protein Danio rerio (zebrafish) 重組斑馬魚 VEGF / VEGFA / VEGF165 蛋白

HS683 人腦細胞

CLEC1B Others Human 人 CLEC1B / CLEC2 人細胞裂解液 (陽性對照)

SW 780 [SW-780, SW780]人膀胱移行細胞癌 SW 780 [SW-780, SW780] in human bladder ansitional cell carcinoma L-15培養(yǎng)基(GIBCO)+10%FBS

大額牛皮膚成纖維樣細胞;BOS-2

大鼠淋巴纖維細胞(RLF)(5×105) BPH-1, 人細胞 Human

CL-0373KiMA(人胚腎上皮細胞系)5×106cells/瓶×2

CNKSR3 Others Human 人 MAGI1 / CNKSR3 桿狀病毒-昆蟲細胞裂解液 (陽性對照)

人肝細胞總RNAHH NA

大耳山羊皮膚細胞;LDG-3 B淋巴細胞，WEHI 22.1細胞 M5076細胞，小鼠網(wǎng)織細胞

人胚肺二倍體細胞;HEL-2

HA Others H11N2 甲型 H11N2 (A/duck/Yangzhou/906/2002) 血凝素 (Hemagglutinin / HA) 人細胞裂解液 (陽性對照)

粘液樣脂肪蛋白FUS1抗體品牌 VEGFA Protein Danio rerio (zebrafish) 重組斑馬魚 VEGF / VEGFA / VEGF165 蛋白

HS683 人腦細胞

CLEC1B Others Human 人 CLEC1B / CLEC2 人細胞裂解液 (陽性對照)

SW 780 [SW-780, SW780]人膀胱移行細胞癌 SW 780 [SW-780, SW780] in human bladder ansitional cell carcinoma L-15培養(yǎng)基(GIBCO)+10%FBS

大額牛皮膚成纖維樣細胞;BOS-2

大鼠淋巴纖維細胞(RLF)(5×105) BPH-1, 人細胞 Human